Hemorheology and tissue oxygenation in hypertensives with lipoidoproteinosis and peripheral occlusive arterial disease (POAD) treated with sulodexide and pravastatine and evaluated with laser assisted optical rotational red cell analyzer (LORCA) and transcutaneous oxymetry

Minerva Cardioangiologica

Volumn 47, Issue 10, 1999, Pages 351-359

  Cicco, G ^a   Stingi, G D ^b   Vicenti, P ^b   Tarallo, M S ^b   Pirrelli, A ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

Hemorheology; Hypertension, peripheral vascular diseases; Pravastatin; Sulodexide

Indexed keywords

PRAVASTATIN; SULODEXIDE;

ADULT; ANALYZER; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD RHEOLOGY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPOID PROTEINOSIS; LOW CALORY DIET; MALE; OBESITY; OPTICAL ROTATION; ORAL DRUG ADMINISTRATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SODIUM RESTRICTION; TISSUE OXYGENATION; TRANSCUTANEOUS OXYGEN MONITORING;

ADULT; AGED; ANTILIPEMIC AGENTS; BLOOD GAS MONITORING, TRANSCUTANEOUS; FEMALE; GLYCOSAMINOGLYCANS; HEMORHEOLOGY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTENSION; LASER-DOPPLER FLOWMETRY; LASERS; LIPOID PROTEINOSIS OF URBACH AND WIETHE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PRAVASTATIN;

EID: 0032761986     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ajmani KS. Hypertension and hemorheology clinical hemorheology and microcirculation. IOS Press 1997;17: 397-420.
2. Lip GYH. Fibrinogen and cardiovascular disorders. Q J Med 1995;155-65.
3. Lip GYH, Beevers DG. Abnormalities of rheology and coagulation in hypertension. J Human Hypertens 1994;8:693-702.
4. Cox RH. Mechanical properties of arteries in hypertension. In: Lee RMKW, editor. Blood vessel changes in hypertension: structure and function. Boca Raton (Florida, USA): CRC Press 1989;I(4):65-98.
5. Ito H. Vascular changes in pulmonary hypertension. In: Lee RMKW, editor. Blood vessel changes in hypertension: structure and function. Boca Raton (Florida, USA): CRC Press 1989;I(5):99-122.
6. Chris R. Triggle reactivity and sensitivity changes of blood vessels in hypertension. In: Lee RMKW, editor. Blood vessel changes in hypertension: structure and function. Boca Raton (Florida, USA): CRC Press 1989; I(2):25-44.
7. Julian H. Lombard neural and local control of the Microcirculation in hypertension. In: Lee RMKW, editor. Blood vessel changes in hypertension: structure and function. Boca Raton (Florida, USA): CRC Press 1989;II(5):91-110.
8. Mohandas N, Clark MR, Jacobs MS, Sholet SB. Analysis of factors regulating erythrocyte deformability. J Clin Invest 1980;66:563-73.
9. Schmid-Schönbein H, Rieger H, Fischer T. Blood fluidity as a consequence of red cell fluidity: flow properties of blood and flow behaviour of blood in vascular diseases. Angiology 1980;31:301-19.
10. Shiga T, Maeda N. Influence of membrane fluidity on erythrocyte functions. Biorheology 1980;17:484-99.
11. Dintenfass L. A new outlook on body fluid viscosity and cell function: concluding remarks and discussion. Clin Hemorheol 1990;10:611-6.
12. Maeda N, Shiga T. Velocity of oxygen transfer and erythrocyte rheology. News Physiol Sci 1994;9:22-7.
13. Cicco G, Pirrelli A. Emoreologia clinica ed ipertensione arteriosa. Minerva Cardioangiol 1993;41:6:213-23.
14. Cesarone MR, Laurora G, Belcaro GU. Microcirculation in systemic hypertension. Angiology 1992;43(11): 899-903.
15. Shore AC, Tooke JE. Microvascular function in human essential hypertension. J Hypertension 1994;12(7): 717-28.
16. Cicco G, Vicenti P, Pirrelli A, van der Kleij AJ. Peripheral perfusion and tissue oxygenation improvement induced by antihypertensive medication combined with lipoidoproteinosis treatment. In: Nemoto, Lamanna, editors. Oxygen transport to tissue XVIII. New York: Plenum Press 1997;5(32):261-6.
17. Mchedlishvili G. New evidence for involvement of blood rheological disorders in rise of peripheral resistance in essential hypertension. Clin Haemorheology and Microcirculation IOS Press 1997;17:31-9.
18. Caimi G. Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in essential hypertension. Clin Hemorheology and Microcirculation IOS Press 1997;17:199-208.
19. Cicco G, Dolce E, Mancini M, Pirrelli A. Atherosclerosis and hemorheology in hypertension: organ damage. Bari: Med J Surg Med IXIA Ed, 1994;3:131-8.
20. Cicco G, Pirrelli A. Hemorheology and tissue oxygen transport during hypertension. Clin Hemorheology and Microcirculation IOS Press 1998;19:1:61-3.
21. Fredrickson DS, Goldstein JL, Brown JS. The familial hyperlipoproteinemias. In: Stanburg JB, Wyngaarden JB, Fredrickson DS, editors. The metabolic basis of inherited disease. New York: Mc Graw Hill 1978:604-45.
22. 2 Regional Perfusion Index to quantify tissue perfusion in peripheral vascular disease. AmJ Surg 1983;197:337-43.
23. van der Kleij AJ, Bakker DJ. Oximetry. In: Oriani G, Marroni A, Wattel F, editors. Handbook of hyperbaric medicine. Milano: Springer Verlag Ed. 1996:670-5.
24. Hardeman MR, Goedhart PT, Dobbe JGG, Lettinga KP. Laser-assisted optical rotational red cell analyser (LORCA) 1. A new instrument for measurement of various structural hemorheological parameters. Clin Hemorheology 1994;14:605-18.
25. Cicco G, Vicenti P, Pirrelli A, Hardeman MR. In vitro effect of defibrotide on red cell rheology as measured with the Laser-assisted Optical rotational Red Cell Analyzer (LORCA) Clin. Hemorheology 1995;15(3): 44-558.
26. Cicco G, Vicenti P, Pirrelli A, Hardeman MR. In vitro effect of defibrotide on red blood cell rheology and measured with LORCA. Biorheology 1995;32(2/3):SP9.
27. Cicco G, van der Kleij AJ, Pirrelli A. Haemorheology and tissue oxygenation in hypertensives with peripheral occlusive arterial disease (POAD). XXVI ISOTT Annual Meeting Budapest Abstract Book 1998;39:137.
28. Cicco G, van der Kleij AJ, Vicenti P, Stingi GD, Manicone A, Dolce E et al. Laser assisted optical rotational red cell analyser (LORCA) in clinical practice. In: Adv in Exp Med and Biol 1999;471:631-7. Ed Plenum Press, NY, USA.
29. Cicco G, Pirrelli A. Red blood cell deformahility, blood viscosity and tissue oxygenation in hypertension. 2nd Intern. Conference on Hemorheology and tissue oxygenation in hypertension and vascular diseases Bari Italy Abstract Book 1998;3;27.
30. Zipursky A, Brown E, Palko J, Brown E. The erythrocyte differential count in newborn infants Am J Ped Haemat Oncol 1983;5(1):45-51.
31. Forconi S. Relationship between erythrocyte morphology and deformability. Boletin de la Societade Portuguesa de Emorreologia e Microcirculaçao, Eur Conf Haemorheol Lisboa 1997:L2.
32. Forconi S, Turchetti V, De Matteis C, Leoncini F, Pierolini F, Tribalzini L et al. Behaviour of blood viscosity intraerythrocytic calcium,total erythrocyte calcium and erythrocytic morphology in ischaemic diseases. Roma: Proceed XVII Fur Conf on Microcirculation 1994:68.
33. Alberts AW. HMG Co A Reductase Inhibitors - The development. In: Stokes III J, Mancini M, editors. Hypercholesterolemia: Clinical and therapeutic implications (Atherosclerosis Reviews Vol 18). New York: Raven Press 1988:123-31.
34. Andriuoli G, Mustacchi R, Barbanti M. Antithrombotic activity of a glycosaminoglycan (Sulodexide) in rats. Thromb Res 1984;43:81-6.
35. Iacoviello L, Pawlak K, D'Adamo MC, Buczko W, Donati MB. Antithrombotic activity of clermatan sulphates, heparin and their combination in an arterial model of thrombosis in rats. Thromb Haemostas 1996.
36. Barbanti M, Guizzardi S, Calanni F, Marchi E, Barbini M. Antithrombotic and thrombolytic activity of Sulodexide in rats. Int J Clin Lab Res 1992;22:179-84.
37. Radhkrishnamurthy B, Ruiz HA, Srinivasan SR, Preau W, Dalferes EDR, Berenson GS. Studies of glycosaminoglycan composition and biological activity of vessel a hypolipidemic agent. Atherosclerosis 1978;31:217-29.
38. Tarugi P, Tiozzo R, Barbanti M, Calandra S, Mastacchi R. Effect of Sulodexide a heparin-like compound, on. experimental atherosclerosis in the rabbit Med. Sci Res 1987;15:1071-2.
39. Radhkrishnamurthy B, Sharma C, Bhandaru RR, Berenson GS, Stasnzani L, Mustacchi R. Studies of chemical and biological properties of a fraction of Sulodexide, a heparin-like glycosaminoglycan. Atherosclerosis 1986;60:141-9.
40. Barbanti M, Aldini R, Barbara L, Simoni P, Stanzani L, Mastacchi R. Effect of Sulodexide, a heparin-like compound, on. VLDL-triglycericle in the perfused rat liver IRCS Med Sci 1985;13:1147-8.
41. Mazzi C, Mainini E, Morandi G, Martinelli I. Effetto del Sulodexide sui fattori determinanti della micro e della macroangiopatia diabetica: studio clinico-metabolico. Farmaci 1984;8:439-48.
42. Caramelli L, Mirchioni R, Carini A. Effectiveness of short-term Sulodexide treatment on, peripheral vascular disease clinical manifestations. Eur Rev Med Pharmac Sci 1988;X:55-8.
43. Ceriello A, Quatraro A, Ettorre M, Marchi K, Barbanti M, Giuliano D. Glycosaminoglycans administration decreases high fibrinogen plasma levels in diabetic patients. Diab Nutr Metab 1993;6:1-4.
44. Amoretti R, Teodonio C. Sulodexide e macroangiopatia diabetica. Studio clinico. Agg Med Chir 1985;3:1-6.